Cancel
Known information
- Holds a JD from Stanford Law School
- Holds an MBA from Gies College of Business, University of Illinois Urbana-Champaign
- Obtained a BA in biology from Bryn Mawr College
- Previously served as VP, Head of Business Development & Investor Relations at Myovant Sciences
- Earlier in her career, was a member of the Transactions team with Roche Pharma Partnering
- Began her career as a corporate attorney at Ropes & Gray LLP
- Later worked in the Office of the General Counsel at Harvard University
- Serves as an independent director on the Board of Directors of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT)
About TRex Bio
TRex Bio is a biotechnology company that develops treatments for immune-mediated diseases using a human tissue-based platform combined with machine learning and high-throughput '-omics'.
Report inaccurate information
